I am/have/had
I am looking for
Advanced Filters
Found 2 clinical trials
Bevacizumab Combined With Gefitinib in the Treatment of Advanced NSCLC
To compare the efficacy and safety of gefitinib combined with bevacizumab and gefitinib in the treatment of L858R positive mutation in exon 21 of EGFR gene in advanced NSCLC.
ejection fraction
renal function
metastasis
aptt
measurable disease
- 0 views
- 05 Aug, 2020
Clinical Trial of YH25448(Lazertinib) as the First-line Treatment in Patients With EGFR Mutation Positive Locally Advanced or Metastatic NSCLC (LASER301)
This Phase III study will be conducted to evaluate the efficacy and safety of YH25448 as first-line treatment in locally advanced or metastatic Non-small Cell Lung Cancer (NSCLC) patients with EGFR mutations
small cell lung cancer
lazertinib
adenocarcinoma
gefitinib
curative surgery
- 0 views
- 16 Feb, 2024
- 29 locations